Disorders of the Liver Flashcards
Formula for Maddrey Discriminant Function Score
4.6 x (Patient PT - Control PT + Total Bilirubin in mg/dL)
Components of the Model for End-Stage Liver Disease (MELD) Score
Total bilirubin, creatinine, and INR
Most commonly implicated antibiotic in drug-induced liver disease
Amoxicillin-clavulanate
Most specific histologic criteria for autoimmune hepatitis
Interface hepatitis with lymphocytes and plasma cells in portal, periportal, or lobular areas
Absolute indications for treatment of autoimmune hepatitis (4)
(1) AST >10x, (2) AST >2x with gamma-globulin >2x, (3) bridging or confluent necrosis on biopsy, (4) symptoms: fever, nausea, vomiting, jaundice
Risk factors for progressive hepatic fibrosis in nonalcoholic fatty liver disease (4)
(1) Age >50, (2) BMI >28, (3) serum triglyceride levels >150 mg/dL, (4) ALT >2x
Most common screening test for Wilson disease
Serum ceruloplasmin
Kayser-Fleischer rings in Wilson syndrome indicate copper deposition in this layer of the cornea
Descemet membrane
Pathognomonic finding on liver biopsy in primary biliary cirrhosis characterized by focal duct obliteration with granuloma formation
Florid duct lesion
Gold standard for diagnosis of primary sclerosing cholangitis
Cholangiography
Pathologic hallmark of primary sclerosing cholangitis
Fibro-obliterative cholangiopathy
Portal vein pressure at which clinically significant portal hypertension occurs
8-10 mmHg
normal: 3-5 mmHg
Target heart rate when using nonselective beta-blockers for prophylaxis against variceal bleeding
Reduction in resting HR of 25% or 55-60/min
Frequency of surveillance endoscopy in patients with negative screening endoscopy for esophageal varices
Every 2-3 years
Most effective secondary prophylaxis for variceal hemorrhage
Nonselective beta-blockers plus endoscopic variceal band ligation